Missing/wrong data?
Log in to edit
Data from A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study
Author/s
author: Yi-Long Wu, Lin Wu, Qing Zhou, Baohui Han
Work details
Publication date
March 31, 2023
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.